$VOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vor Biopharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Vor Biopharma Inc.. Get notifications about new insider transactions in Vor Biopharma Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | J | 43.10 | 242,656 | 10,458,474 | 8,539,921 | 8.3 M to 8.5 M (+2.92 %) |
| Apr 05 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | J | 43.10 | 755,726 | 32,571,791 | 755,726 | 0 to 755.7 K |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 3,846,152 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Alexandria Venture Investments ... | 10% Owner | Buy | C | 0.00 | 282,804 | 0 | 282,804 | 0 to 282.8 K |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | C | 0.00 | 19,230,770 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | C | 0.00 | 51,464,036 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | C | 0.00 | 3,812,500 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | C | 0.00 | 22,637,875 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 18.00 | 130,970 | 2,357,460 | 1,825,326 | 1.7 M to 1.8 M (+7.73 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 18.00 | 2,848,596 | 51,274,728 | 8,297,265 | 5.4 M to 8.3 M (+52.28 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | C | 0.00 | 1,414,026 | 0 | 1,694,356 | 280.3 K to 1.7 M (+504.41 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | C | 0.00 | 3,784,120 | 0 | 5,448,669 | 1.7 M to 5.4 M (+227.34 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | C | 0.00 | 280,330 | 0 | 280,330 | 0 to 280.3 K |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | C | 0.00 | 1,664,549 | 0 | 1,664,549 | 0 to 1.7 M |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 19,230,768 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 19,230,768 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 45,000,000 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% Owner | Buy | P | 18.00 | 444,444 | 7,999,992 | 1,858,470 | 1.4 M to 1.9 M (+31.43 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% Owner | Buy | C | 0.00 | 1,414,026 | 0 | 1,414,026 | 0 to 1.4 M |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% Owner | Buy | P | 18.00 | 111,111 | 1,999,998 | 4,833,959 | 4.7 M to 4.8 M (+2.35 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% Owner | Buy | C | 0.00 | 1,414,026 | 0 | 4,722,848 | 3.3 M to 4.7 M (+42.74 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% Owner | Buy | C | 0.00 | 3,308,822 | 0 | 3,308,822 | 0 to 3.3 M |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | Chief Financial Off ... | Option Exercise | C | 0.00 | 48,076 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | Chief Financial Off ... | Buy | C | 0.00 | 3,534 | 0 | 29,269 | 25.7 K to 29.3 K (+13.73 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Chakraborty Tirtha | Chief Scientific Of ... | Option Exercise | C | 0.00 | 48,076 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Chakraborty Tirtha | Chief Scientific Of ... | Buy | C | 0.00 | 3,534 | 0 | 3,534 | 0 to 3.5 K |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Resnick Joshua | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Patterson Matthew R | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Option Exercise | C | 0.00 | 19,230,768 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Option Exercise | C | 0.00 | 19,230,768 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Option Exercise | C | 0.00 | 45,000,000 | 0 | 0 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Buy | P | 18.00 | 444,444 | 7,999,992 | 1,858,470 | 1.4 M to 1.9 M (+31.43 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Buy | C | 0.00 | 1,414,026 | 0 | 1,414,026 | 0 to 1.4 M |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Buy | P | 18.00 | 111,111 | 1,999,998 | 4,833,959 | 4.7 M to 4.8 M (+2.35 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Buy | C | 0.00 | 1,414,026 | 0 | 4,722,848 | 3.3 M to 4.7 M (+42.74 %) |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director | Buy | C | 0.00 | 3,308,822 | 0 | 3,308,822 | 0 to 3.3 M |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Lundberg Sven Ante | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Lubner David Charles | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Beckman Daniella | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | ANG ROBERT | President and CEO | Option Exercise | A | 18.00 | 51,060 | 919,080 | 51,060 |
Page: 1